{"id":"W3005887319","doi":"10.1097/01.hs9.0000560956.60646.c2","title":"PF668 RESULTS FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL‐401) IN PATIENTS WITH INTERMEDIATE, OR HIGH RISK, RELAPSED/REFRACTORY MYELOFIBROSIS","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Monocytosis; Refractory (planetary science); Internal medicine; Interleukin-3 receptor; Oncology; Phases of clinical research; Ruxolitinib; Myeloid; Clinical trial; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004229216,0.0003824413,0.001206872,0.00009231034,0.00004654462,0.00002072672,0.0001393363,0.0002932327,0.001260385],"category_scores_gemma":[0.0007718987,0.0002435785,0.0002050971,0.0002876488,0.0001170529,0.0001651371,0.00007802845,0.0005546053,0.0001782339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001528112,"about_ca_system_score_gemma":0.0002868932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007881827,"about_ca_topic_score_gemma":0.0006946308,"domain_scores_codex":[0.9965662,0.000291562,0.001386259,0.0007895162,0.0005908783,0.0003755213],"domain_scores_gemma":[0.9964856,0.001537012,0.000748754,0.0007789685,0.000194194,0.0002554966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2562397,0.008233009,0.713201,0.00006131294,0.0003543116,0.00006174321,0.0003986761,0.000005495787,0.00002600159,0.00001283704,0.001809379,0.01959653],"study_design_scores_gemma":[0.3930186,0.02335576,0.5790825,0.0009851656,0.0002699073,8.796534e-7,0.0001854782,0.00003822006,0.001294593,0.00002026535,0.001489187,0.0002595002],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954799,0.00007527856,0.000007670422,0.0001168597,0.0006292518,0.002182198,0.0005427192,0.00004574174,0.0009204171],"genre_scores_gemma":[0.9961492,0.0002359953,0.001695149,0.0001573887,0.0002710489,0.00009987439,0.000601596,0.00005843273,0.0007313011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1367789,"threshold_uncertainty_score":0.9996526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02421052598918092,"score_gpt":0.3103908181273837,"score_spread":0.2861802921382028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}